Moreover, it has been shown that the inhibition of the deubiquitinating enzyme USP10 inhibits proliferation in chronic myeloid leukemia (CML) cells, both in imatinib-sensitive and imatinib-resistance cells [35,36]. Here, USP10 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.